ITXXF yields 166.65% · MRK yields 2.76%● Live data
📍 ITXXF pulled ahead of the other in Year 1
Combined, ITXXF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ITXXF + MRK for your $10,000?
Itaconix plc, together with its subsidiaries, designs, develops, manufactures, and sells bio-based polymers for personal care, home care, and industrial sectors in North America and Europe. The company's home care and industrial products include Itaconix TSI 322, Itaconix DSP 2K, Itaconix TSI 122, and Itaconix VELASOFT water soluble polymers; and Itaconix ZINADOR 22L and 35L, which are water soluble odor neutralizers. Its personal care products comprise Itaconix VELAFRESH ZP20 and ZP30 that are water soluble fixating complexes; and Nouryon Amaze SP, a hair styling ingredient. The company was formerly known as Revolymer plc and changed its name to Itaconix plc in February 2017. Itaconix plc was incorporated in 2012 and is headquartered in Stratham, New Hampshire.
Full ITXXF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.